Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jounce Therapeutics, Inc. | Chief Medical Officer | Common Stock | 103K | $191K | $1.85 | Jan 10, 2023 | Direct |
CONSTELLATION PHARMACEUTICALS INC | Director | Stock Options (Right to buy) | 0 | Jul 15, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JNCE | Jounce Therapeutics, Inc. | Jan 9, 2023 | 2 | -$10.3K | 4 | Jan 11, 2023 | Chief Medical Officer |
JNCE | Jounce Therapeutics, Inc. | Feb 1, 2022 | 2 | $0 | 4 | Feb 3, 2022 | Chief Medical Officer |
JNCE | Jounce Therapeutics, Inc. | Jan 7, 2022 | 2 | -$57.7K | 4 | Jan 11, 2022 | Chief Medical Officer |
CNST | CONSTELLATION PHARMACEUTICALS INC | Jul 15, 2021 | 4 | $0 | 4 | Jul 19, 2021 | Director |
CNST | CONSTELLATION PHARMACEUTICALS INC | Jun 2, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director |